BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li SC, Tachiki LM, Kabeer MH, Dethlefs BA, Anthony MJ, Loudon WG. Cancer genomic research at the crossroads: realizing the changing genetic landscape as intratumoral spatial and temporal heterogeneity becomes a confounding factor. Cancer Cell Int. 2014;14:115. [PMID: 25411563 DOI: 10.1186/s12935-014-0115-7] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
Number Citing Articles
1 Yang H, Zhang X, Cai XY, Wen DY, Ye ZH, Liang L, Zhang L, Wang HL, Chen G, Feng ZB. From big data to diagnosis and prognosis: gene expression signatures in liver hepatocellular carcinoma. PeerJ 2017;5:e3089. [PMID: 28316892 DOI: 10.7717/peerj.3089] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
2 Castven D, Fischer M, Becker D, Heinrich S, Andersen JB, Strand D, Sprinzl MF, Strand S, Czauderna C, Heilmann-Heimbach S, Roessler S, Weinmann A, Wörns MA, Thorgeirsson SS, Galle PR, Matter MS, Lang H, Marquardt JU. Adverse genomic alterations and stemness features are induced by field cancerization in the microenvironment of hepatocellular carcinomas. Oncotarget 2017;8:48688-700. [PMID: 28415775 DOI: 10.18632/oncotarget.16231] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
3 Kim JS, Bae GE, Kim SH, Choi MK, Yeo MK. Serum-Based KRASG12/G13 Mutation Detection Using Droplet Digital PCR: Clinical Implications and Limitations in Colorectal Adenocarcinoma With Tumor Heterogeneity. Front Oncol 2020;10:604772. [PMID: 33585224 DOI: 10.3389/fonc.2020.604772] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Li SC, Rangel AD, Kabeer MH. Precision Technique for Splenectomy Limits Mouse Stress Responses for Accurate and Realistic Measurements for Investigating Inflammation and Immunity. Bio Protoc 2019;9:e3317. [PMID: 31497622 DOI: 10.21769/BioProtoc.3317] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 Cai Y, Mei J, Xiao Z, Xu B, Jiang X, Zhang Y, Zhu Y. Identification of five hub genes as monitoring biomarkers for breast cancer metastasis in silico. Hereditas 2019;156:20. [PMID: 31285741 DOI: 10.1186/s41065-019-0096-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
6 Zapata L, Susak H, Drechsel O, Friedländer MR, Estivill X, Ossowski S. Signatures of positive selection reveal a universal role of chromatin modifiers as cancer driver genes. Sci Rep 2017;7:13124. [PMID: 29030609 DOI: 10.1038/s41598-017-12888-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
7 Li SC, Kabeer MH. Spatiotemporal switching signals for cancer stem cell activation in pediatric origins of adulthood cancer: Towards a watch-and-wait lifetime strategy for cancer treatment. World J Stem Cells 2018; 10(2): 15-22 [PMID: 29531638 DOI: 10.4252/wjsc.v10.i2.15] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
8 Zhang J, Su Q, Loudon WG, Lee KL, Luo J, Dethlefs BA, Li SC. Breathing Signature as Vitality Score Index Created by Exercises of Qigong: Implications of Artificial Intelligence Tools Used in Traditional Chinese Medicine. J Funct Morphol Kinesiol 2019;4:71. [PMID: 31853512 DOI: 10.3390/jfmk4040071] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
9 Badrinath N, Yoo SY. Recent Advances in Cancer Stem Cell-Targeted Immunotherapy. Cancers (Basel) 2019;11:E310. [PMID: 30841635 DOI: 10.3390/cancers11030310] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 9.0] [Reference Citation Analysis]
10 Stanić D, Grujičić D, Pekmezović T, Bokun J, Popović-Vuković M, Janić D, Paripović L, Ilić V, Pudrlja Slović M, Ilić R, Raičević S, Sarić M, Mišković I, Nidžović B, Nikitović M. Clinical profile, treatment and outcome of pediatric brain tumors in Serbia in a 10-year period: A national referral institution experience. PLoS One 2021;16:e0259095. [PMID: 34699548 DOI: 10.1371/journal.pone.0259095] [Reference Citation Analysis]
11 Li SC, Vu LT, Luo JJ, Zhong JF, Li Z, Dethlefs BA, Loudon WG, Kabeer MH. Tissue elasticity bridges cancer stem cells to the tumor microenvironment through microRNAs: implications for a "watch-and-wait" approach to cancer. Curr Stem Cell Res Ther. 2017;12:455-470. [PMID: 28270089 DOI: 10.2174/1574888x12666170307105941] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
12 Chen X, Wen Q, Stucky A, Zeng Y, Gao S, Loudon WG, Ho HW, Kabeer MH, Li SC, Zhang X, Zhong JF. Relapse pathway of glioblastoma revealed by single-cell molecular analysis. Carcinogenesis. 2018;39:931-936. [PMID: 29718126 DOI: 10.1093/carcin/bgy052] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
13 Mellai M, Annovazzi L, Bisogno I, Corona C, Crociara P, Iulini B, Cassoni P, Casalone C, Boldorini R, Schiffer D. Chondroitin Sulphate Proteoglycan 4 (NG2/CSPG4) Localization in Low- and High-Grade Gliomas. Cells 2020;9:E1538. [PMID: 32599896 DOI: 10.3390/cells9061538] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Rasnic R, Linial M. Chromoanagenesis Landscape in 10,000 TCGA Patients. Cancers (Basel) 2021;13:4197. [PMID: 34439350 DOI: 10.3390/cancers13164197] [Reference Citation Analysis]
15 Song Y, Yan S, Fan W, Zhang M, Liu W, Lu H, Cao M, Hao C, Chen L, Tian F, Zhan Y, Cai L, Xing Y. Identification and Validation of the Immune Subtypes of Lung Adenocarcinoma: Implications for Immunotherapy. Front Cell Dev Biol 2020;8:550. [PMID: 32719796 DOI: 10.3389/fcell.2020.00550] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
16 Rocha RA, Fox JM, Genever PG, Hancock Y. Biomolecular phenotyping and heterogeneity assessment of mesenchymal stromal cells using label-free Raman spectroscopy. Sci Rep 2021;11:4385. [PMID: 33623051 DOI: 10.1038/s41598-021-81991-1] [Reference Citation Analysis]
17 Li SC, Luo J, Lee KL. Cancer Niche as a Garbage Disposal Machine: Implications of TCM-Mediated Balance of Body-Disease for Treatment of Cancer. Online J Complement Altern Med 2019;1:000514. [PMID: 31453571 DOI: 10.33552/OJCAM.2019.01.000514] [Reference Citation Analysis]
18 Byrne-hoffman C, Ii D. A Quantitative Systems Pharmacology Perspective on Cancer Immunology. Processes 2015;3:235-56. [DOI: 10.3390/pr3020235] [Cited by in Crossref: 7] [Article Influence: 1.0] [Reference Citation Analysis]
19 Volpentesta G, Donato G, Ferraro E, Mignogna C, Radaelli R, Sabatini U, La Torre D, Malara N. Pilocytic Astrocytoma-Derived Cells in Peripheral Blood: A Case Report. Front Oncol 2021;11:737730. [PMID: 34778052 DOI: 10.3389/fonc.2021.737730] [Reference Citation Analysis]
20 Birkeland AC, Ludwig ML, Meraj TS, Brenner JC, Prince ME. The Tip of the Iceberg: Clinical Implications of Genomic Sequencing Projects in Head and Neck Cancer. Cancers (Basel) 2015;7:2094-109. [PMID: 26506389 DOI: 10.3390/cancers7040879] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
21 Kumar R, Liu APY, Orr BA, Northcott PA, Robinson GW. Advances in the classification of pediatric brain tumors through DNA methylation profiling: From research tool to frontline diagnostic. Cancer 2018;124:4168-80. [PMID: 30255939 DOI: 10.1002/cncr.31583] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 6.3] [Reference Citation Analysis]
22 Mei J, Wang H, Wang R, Pan J, Liu C, Xu J. Evaluation of X-Ray Repair Cross-Complementing Family Members as Potential Biomarkers for Predicting Progression and Prognosis in Hepatocellular Carcinoma. Biomed Res Int 2020;2020:5751939. [PMID: 32258128 DOI: 10.1155/2020/5751939] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
23 Nadal C, Winder T, Gerger A, Tougeron D. Future perspectives of circulating tumor DNA in colorectal cancer. Tumour Biol 2017;39:1010428317705749. [PMID: 28488528 DOI: 10.1177/1010428317705749] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
24 Kim O, Park EY, Klinkebiel DL, Pack SD, Shin YH, Abdullaev Z, Emerson RE, Coffey DM, Kwon SY, Creighton CJ, Kwon S, Chang EC, Chiang T, Yatsenko AN, Chien J, Cheon DJ, Yang-Hartwich Y, Nakshatri H, Nephew KP, Behringer RR, Fernández FM, Cho CH, Vanderhyden B, Drapkin R, Bast RC Jr, Miller KD, Karpf AR, Kim J. In vivo modeling of metastatic human high-grade serous ovarian cancer in mice. PLoS Genet 2020;16:e1008808. [PMID: 32497036 DOI: 10.1371/journal.pgen.1008808] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
25 Heinrich S, Craig AJ, Ma L, Heinrich B, Greten TF, Wang XW. Understanding tumour cell heterogeneity and its implication for immunotherapy in liver cancer using single-cell analysis. J Hepatol 2021;74:700-15. [PMID: 33271159 DOI: 10.1016/j.jhep.2020.11.036] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
26 Marquardt JU, Andersen JB, Thorgeirsson SS. Functional and genetic deconstruction of the cellular origin in liver cancer. Nat Rev Cancer. 2015;15:653-667. [PMID: 26493646 DOI: 10.1038/nrc4017] [Cited by in Crossref: 166] [Cited by in F6Publishing: 160] [Article Influence: 27.7] [Reference Citation Analysis]
27 Mei J, Hao L, Liu X, Sun G, Xu R, Wang H, Liu C. Comprehensive analysis of peroxiredoxins expression profiles and prognostic values in breast cancer. Biomark Res 2019;7:16. [PMID: 31402980 DOI: 10.1186/s40364-019-0168-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
28 Hervey-Jumper SL, Berger MS. In reply: Reoperation for recurrent high-grade glioma: does tumor genetics play a role? Neurosurgery 2015;76:E497. [PMID: 25635894 DOI: 10.1227/NEU.0000000000000667] [Reference Citation Analysis]